FCGR2B and triple-negative breast carcinoma: Incubation with triple-negative breast cancer (TNBC) cells, MDA-MB-468 and MDA-MB-231, induced significant CD32-CR down-regulation in 78.7% ± 7% and 81.3% ± 8% of engineered T cells, respectively (Fig 3A).